SCHEMBL535803

SCHEMBL535803

CCCCC(=O)OSc1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
ALDH1A1 P00352 5/20 0.44
SMN1; SMN2 Q16637 6/20 0.42
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
RECQL P46063 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 4/20 0.40
HTT P42858 2/20 0.40
NPC1 O15118 2/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
PKM P14618 1/20 0.38
EHMT2 Q96KQ7 1/20 0.38
EHMT1 Q9H9B1 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28254695 0.91 LMNA (0.52) LMNAALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL25399704 0.86 LMNA (0.48) LMNAALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL1607376 0.84 LMNA (0.55) LMNAALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL29573871 0.81 LMNA (0.46) LMNAALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL535804 0.78 ALDH1A1 (0.49) LMNAALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL16897952 0.77 LMNA (0.50) LMNAALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL6257380 0.76 CES2 (0.50) LMNAALDH1A1KMT2AKDM4EMEN1
SCHEMBL28950323 0.76 LMNA (0.47) LMNAALDH1A1SMN1; SMN2KMT2AKDM4E
Valeric Acid SCHEMBL29796187 0.76 ALDH1A1 (0.58) LMNAALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL5162822 0.76 EHMT2 (0.50) LMNAALDH1A1SMN1; SMN2KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105073988-A Anti-CDH3 humanized antibody, drug conjugate thereof, and utilization of same PERSEUS PROTEOMICS INC 2015-11-18 CN claimed
CN-104220595-A Agent conjugates of anti-CDH 3 (P-cadherin) antibodies PERSEUS PROTEOMICS INC 2014-12-17 CN claimed
EP-2414395-A1 ANTI-FCRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE Genentech, Inc. (US) 2012-02-08 EP claimed
WO-2010114940-A1 ANTI-FCRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE GENENTECH, INC. (US) 2010-10-07 WO claimed
CN-118076376-A TGF-beta bearing antigen presenting polypeptide complexes and methods of use thereof 库尔生物制药有限公司 2024-05-24 CN disclosed
CN-116437952-A T cell modulating polypeptides with conjugation sites and methods of use thereof 库尔生物制药有限公司 2023-07-14 CN disclosed
CN-111886241-A Multimeric T cell modulating polypeptides and methods of use thereof 库尔生物制药有限公司 2020-11-03 CN disclosed
CN-110511279-A Oncostatin M receptor antigen binding proteins KINIKSA PHARMACEUTICALS LTD 2019-11-29 CN disclosed
CN-105555803-B Oncostatin M receptor antigen binding proteins 基尼克萨制药有限公司 2019-09-10 CN disclosed
CN-107513105-B Oncostatin M receptor antigen binding proteins 基尼克萨制药有限公司 2019-08-16 CN disclosed
CN-108779146-A Peptide derivant and application thereof 东丽株式会社 2018-11-09 CN disclosed
CN-102770456-B Multispecific antibodies, antibody analogs, compositions and methods 弗·哈夫曼-拉罗切有限公司 2018-04-06 CN disclosed
CN-107513105-A Oncostatin M receptor antigen binding proteins 基尼克萨制药有限公司 2017-12-26 CN disclosed
CN-107337734-A Multi-specificity antibody, antibody analog, composition and method 弗·哈夫曼-拉罗切有限公司 2017-11-10 CN disclosed
CN-105073988-A Anti-CDH3 humanized antibody, drug conjugate thereof, and utilization of same PERSEUS PROTEOMICS INC 2015-11-18 CN disclosed
CN-104797600-A Antibody capable of specifically recognizing transferrin receptor NAT UNIVERSITY CORP UNIVERSITY OF MIYAZAKI 2015-07-22 CN disclosed
CN-104220595-A Agent conjugates of anti-CDH 3 (P-cadherin) antibodies PERSEUS PROTEOMICS INC 2014-12-17 CN disclosed
CN-102770456-A Multispecific antibodies, antibody analogs, compositions and methods GENENTECH INC 2012-11-07 CN disclosed